Clinical TrialsSearch results
Number of results: 232
Other
- Phase III study of Z-100 in uterine cervix cancer patients
- primary uterine cervix cancer
- ZERIA Pharmaceutical Co.,Ltd.
- 2005-09-13
Recruiting
- Nd:YAG picosecond laser treatment for melanocytic naevi
- melanocytic naevi
- Yuki Yamamoto
- 2023-04-11
Other
- A randomized phase III trial of postoperative adjuvant oral fluoropyrimidine vs. sequential paclitaxel / oral fluoropyrimidine; and UFT vs. S1 for T3 / T4 gastric carcinoma: the Stomach Cancer Adjuvant Multi-institutional Trial Group (SAMIT) Trial
- Gastric Cancer
- Young Leaders' Program (YLP), Nagoya University School of Medicine
- 2005-09-01
Completed
- Efficacy of 5-aminolevulinic acid for Upper urinary tract carcinoma
- Upper urinary tract urothelial carcinoma
- Yoshida Takashi
- 2020-04-23
Recruiting
- HYA slows the elevation of postprandial blood glucose level in patients with type 1 diabetes.
- Type 1 diabates
- Yasushi Furukawa
- 2022-10-14
Completed
- Remimazolam and desflurane for arterial oxygen partial pressure during unilateral lung ventilation : randomized controlled trial
- Lung tumor etc.
- Yamamoto Kasumi
- 2022-03-17
Other
- A Phase II Study of Combination Chemotherapy using TS-1 and Cisplatin with Concurrent Thoracic Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer
- Locally Advanced Non-Small Cell Lung Cancer
- West Japan Oncology Group
- 2008-09-12
Other
- A phase III trial comparing preoperative chemotherapy to chemoradiotherapy before surgery in patients with pathologically-confirmed stage IIIA-N2 non-small cell lung cancer.
- Pathologically confirmed stage IIIA-N2 non-small cell lung cancer
- West Japan Oncology Group
- 2005-09-14
Other
- A Randomized Phase II study of Carboplatin and Paclitaxel or Gemcitabine and Vinorelbine in ECOG PS2 patients with advanced non-small cell lung cancer
- ECOG PS2 patients with advanced non-small cell lung cancer
- West Japan Oncology Group
- 2005-08-31
Other
- Dose-intensive weekly combination chemotherapy (cisplatin, vincristine, doxorubicin and etoposide) followed by cisplatin-etoposide therapy with concurrent thoracic irradiation: evaluation of a new treatment for limited-disease small-cell lung cancer.
- limited-disease small-cell lung cancer
- West Japan Oncology Group
- 2005-09-09